Why the study?
Social determinants of health may influence clinical presentation, management, and outcomes in atrial fibrillation, but their associations with trajectories in symptom burden during treatment remain unclear.
Do adverse social determinants of health associate with blunted improvements in patient-reported symptom burden in patients undergoing atrial fibrillation treatment?
Cohort (n=516)
Yes
Do adverse social determinants of health associate with blunted improvements in patient-reported symptom burden in patients undergoing atrial fibrillation treatment?
Mean Difference: -6.4 (95% CI -11–-1.9)
Adverse social determinants of health, particularly living in highly deprived neighborhoods and being of non-Hispanic Black race, are associated with significantly blunted improvements in patient-reported symptom burden and quality of life after 1 year of atrial fibrillation management.
BACKGROUND: Social determinants of health (SDoH) may influence the clinical presentation, management, and outcomes related to atrial fibrillation (AF). OBJECTIVES: This study aims to examine the associations of SDoH with trajectories in AF symptom burden in participants undergoing AF treatment. METHODS: The authors designed a prospective, observational cohort study at an academic medical center in a large U.S. metropolitan city serving predominantly low-income and underinsured populations. Participants were those referred with an initial diagnosis of paroxysmal or persistent AF. Adverse SDoH, including NDI (National Deprivation Index), insurance status, language, and marital status, as well as proxies for structural and systemic biases through race, ethnicity, and sex were assessed. Participants received standard care with study-specific follow-up at 1 year. The outcome was scores from the Atrial Fibrillation Effect on Quality-of-Life (AFEQT) questionnaire (higher scores representing better quality of life). RESULTS: Of 515 participants who had follow-up assessments; 41% were non-Hispanic Black, 40% were non-Hispanic White, and 18% were Hispanic/Latinx. The mean AFEQT score at baseline was 73 (of 100) and at follow-up was 80 (SD: 19). Participants living in higher levels of NDI experienced 6.4 (95% CI: 1.9-11.0) point smaller increase in AFEQT scores compared to those in lower levels of NDI, and non-Hispanic Blacks experienced a 4.6 (95% CI: 1.1-8.0) point smaller increase compared to non-Hispanic Whites. There were 61 admissions for decompensated heart failure, 53 ischemic strokes, and 47 all-cause mortality events. CONCLUSIONS: After adjusting for clinical factors, adverse SDoH associate with blunted improvements in AF symptom burden after 1 year of clinical management.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2025) conducted a cohort in Atrial Fibrillation (n=516). Adverse Social Determinants of Health (Highest National Deprivation Index Quartile) vs. Lowest National Deprivation Index Quartile was evaluated on Change in global Atrial Fibrillation Effect on Quality-of-Life (AFEQT) score at 1 year (MD -6.4, 95% CI -11.0 to -1.9).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: